|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300074551 |
|
最近更新日期: Date of Last Refreshed on: |
2023-08-09 15:12:26 |
|
注册时间: Date of Registration: |
2023-08-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
头皮针电刺激疗法治疗外周性眩晕的疗效研究 |
|
Public title: |
Research on the Effectiveness of Scalp Acupuncture Electrostimulation for Peripheral Vertigo |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
头皮针电刺激疗法治疗外周性眩晕的疗效研究 |
|
Scientific title: |
Research on the Effectiveness of Scalp Acupuncture Electrostimulation for Peripheral Vertigo |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张肖 |
研究负责人: |
王贺 |
|
Applicant: |
Zhang Xiao |
Study leader: |
Wang He |
|
申请注册联系人电话: Applicant telephone: |
+86 176 7176 5028 |
研究负责人电话:
Study leader's |
+86 189 9556 5854 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
nmb202@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
545260512@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
湖北省武汉市菱角湖路11号湖北省中西医结合医院耳鼻咽喉科 |
研究负责人通讯地址: |
湖北省武汉市菱角湖路11号湖北省中西医结合医院耳鼻咽喉科 |
|
Applicant address: |
Department of Otorhinolaryngology, Hubei Hospital of Integrated Traditional Chinese and Western Medicine, located at 11 Liujiaohu Road, Wuhan City, Hubei Province, China. |
Study leader's address: |
Department of Otorhinolaryngology, Hubei Hospital of Integrated Traditional Chinese and Western Medicine, located at 11 Liujiaohu Road, Wuhan City, Hubei Province, China. |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
湖北省中西医结合医院 |
||
|
Applicant's institution: |
Hubei Hospital of Integrated Traditional Chinese and Western Medicine |
||
|
研究负责人所在单位: |
湖北省中西医结合医院 |
||
|
Affiliation of the Leader: |
Hubei Hospital of Integrated Traditional Chinese and Western Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
(2023)伦理第(研054)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
湖北省中西医结合医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Hubei Hospital of Integrated Traditional Chinese and Western Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-07-31 00:00:00 | ||
|
伦理委员会联系人: |
王贺 |
||
|
Contact Name of the ethic committee: |
wanghe |
||
|
伦理委员会联系地址: |
湖北省武汉市菱角湖路11号 |
||
|
Contact Address of the ethic committee: |
11 Liujiaohu Road, Wuhan City, Hubei Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 27 8548 9871 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
545260512@qq.com |
|
研究实施负责(组长)单位: |
湖北省中西医结合医院 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Hubei Hospital of Integrated Traditional Chinese and Western Medicine |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
湖北省武汉市菱角湖路11号 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
11 Liujiaohu Road, Wuhan City, Hubei Province, China |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
医院内的科研项目经费 |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Scientific research project funds of the hospital |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
外周性眩晕 |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
Peripheral vertigo |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
探讨头皮针电刺激疗法治疗外周性眩晕的疗效 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
Research on the Effectiveness of Scalp Acupuncture Electrostimulation for Peripheral Vertigo |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
①符合中华医学会《老年人头晕 / 眩晕诊疗多学科专家共识》外周性眩晕相关疾病诊断标准;②年龄≥18 周岁、年龄≤80 周岁;③同意使用头皮针电刺激治疗者。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
(1) Aligned with the diagnostic criteria for peripheral vertigo-related conditions outlined by the Chinese Medical Association in the "Multidisciplinary Expert Consensus on Diagnosis and Treatment of Dizziness/Vertigo in the Elderly." (2) Individuals aged 18 years or older but no older than 80 years were included. (3) Participants consented to receiving scalp acupuncture electrical stimulation treatment. |
||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
1.患严重心脏系统疾病、精神系统等及不能接受电刺激者; 2.中枢性眩晕; 3.有抑郁症、双相情感障碍等精神疾病史; 4.合并脑卒中、癌症等其他严重疾病; 5.中途退出或脱离本研究; 6.主观拒绝使用头皮针电刺激治疗者。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
(1) Experiencing severe cardiovascular or mental disorders and deemed unsuitable for electrical stimulation treatment. (2) Central vertigo cases. (3) Individuals with a pre-existing history of depression, bipolar disorder, or other mental illnesses prior to the onset of their condition. (4) Individuals complicated with severe conditions like stroke or cancer. (5) Participants who withdrew or disengaged from the study. (6) Participants who subjectively declined to undergo scalp acupuncture electrical stimulation treatment. |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-08-01 00:00:00至 To 2026-08-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-08-01 00:00:00 至 To 2026-08-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
研究人员使用随机数字表法生成随机序列。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The researcher created the random sequence using the method of a random number table. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
https://edc.cttq.com/environmentSelect.aspx |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
https://edc.cttq.com/environmentSelect.aspx |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
1.使用Microsoft Office Excel工作表可以轻松管理病例记录。这种电子解决方案可以有效和有组织地跟踪案件,并能够根据需要输入和更新相关信息。” 2.这个项目的电子采集和管理系统使用的是约翰开发的麦金塔产品JMP。该系统提供了强大的数据分析和可视化功能,可以有效地管理和解释大型数据集。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
1.Microsoft Office Excel worksheets offer a convenient way to manage case records. This electronic solution facilitates efficient and organized case tracking, enabling the input and update of pertinent information as required. 2.The electronic acquisition and management system for this project employs JMP, a Macintosh product developed by John. This system provides powerful data analysis and visualization capabilities, streamlining the management and interpretation of extensive datasets. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |